6 Astonishing Sun Temples in India: Architectural Marvels
Discover India's magnificent Sun temples that blend divine worship with extraordinary architectural brilliance across different historical periods.
Discover India's magnificent Sun temples that blend divine worship with extraordinary architectural brilliance across different historical periods.
Major Indian companies including L&T, HPCL, RailTel, and Coal India set to announce Q2 FY2025 earnings today. Get insights on market expectations and sector performance in this comprehensive earnings analysis.
Major Indian companies including TVS Motor, Adani Green Energy, Tata Capital, and Jindal Steel & Power declare Q2 FY2025 earnings today. Get insights into market expectations and performance indicators for these key stocks.
Major Indian companies including Adani Energy Solutions, Indus Towers, and Indian Oil Corporation set to declare Q2 FY2025 results today. Get complete list and market expectations.
The 1000-year-old Deo Sun Temple in Aurangabad prepares for massive Chhath celebrations with enhanced facilities for 150,000 expected devotees. Discover the temple's rich history and special arrangements.
The millennium-old Deo Sun Temple in Bihar's Aurangabad prepares for over 150,000 devotees during Chhath Puja 2024 with enhanced facilities and special arrangements.
Get ready for a blockbuster week as corporate giants including L&T, ITC, Indian Oil, Swiggy, and Adani Green prepare to announce Q2 FY2025 results, setting the tone for market direction.
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
The Institute of Chartered Accountants of India is set to declare CA September 2025 exam results. Get complete details on expected dates, step-by-step checking process, and important guidelines for candidates.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Aditya Birla Sun Life AMC reports flat Q2 profit of ₹241 crore while revenue climbs 9%. Discover how India's leading asset manager navigated market challenges and maintained strong operational performance.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Get ready for a blockbuster week as corporate India's Q2 earnings season hits high gear. Hindustan Unilever, SBI Life Insurance, and over 40 other companies set to unveil their financial performance, offering crucial insights into market direction and eco
ICICI Bank reports robust Q2 FY2024 performance with 5.2% net profit growth, 23.8% surge in net interest income, and improved asset quality. Complete analysis of the banking giant's quarterly results.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Major Indian banking and cement stocks including HDFC Bank, ICICI Bank, Yes Bank, PNB, Ultratech Cement and UTI Asset Management to announce Q2 FY24 results today. Get expert analysis on what to expect from these key players.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.